Abdrabou AKotb, Sharif FAl, Fakih REl, Zahrani HAl, Yamany RAl, Saleh M, AlHayli S, Somali ZAl, Alotaibi A, AlShaibani AF, et al. Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients. Ann Saudi Med. 2024;44(2):93-103.